Arsenic Hepatic Sinusoidal Export is Stimulated by Methylselenocysteine and Mediated by Multidrug Resistance Protein 4 (MRP4/ABCC4)

被引：0
|
作者：
Leslie, Elaine M. [1 ]
Zhou, Janet R. [1 ]
Kaur, Gurnit [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
基金：
加拿大健康研究院;
关键词：
D O I：
10.1124/jpet.122.537850
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
220
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro
    Norris, MD
    Smith, J
    Tanabe, K
    Tobin, P
    Flemming, C
    Scheffer, GL
    Wielinga, L
    Cohn, SL
    London, WB
    Marshall, GM
    Allen, JD
    Haber, M
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (04) : 547 - 553
  • [42] Release of Platelet-Derived Sphingosine-1-Phosphate Involves Multidrug Resistance Protein 4 (MRP4/ABCC4) and Is Inhibited by Statins
    Vogt, Katja
    Mahajan-Thakur, Shailaja
    Wolf, Robert
    Broderdorf, Susanne
    Vogel, Conny
    Boehm, Andreas
    Ritter, Christoph A.
    Graeler, Markus
    Oswald, Stefan
    Greinacher, Andreas
    Kroemer, Heyo K.
    Jedlitschky, Gabriele
    Rauch, Bernhard H.
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (01) : 132 - 142
  • [43] MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease
    Belleville-Rolland, Tiphaine
    Sassi, Yassine
    Decouture, Benoit
    Dreano, Elise
    Hulot, Jean-Sebastien
    Gaussem, Pascale
    Bachelot-Loza, Christilla
    PHARMACOLOGICAL RESEARCH, 2016, 107 : 381 - 389
  • [44] CONTRIBUTION OF ABCC4 (MRP4)-MEDIATED GASTRIC ABSORPTION TO THE ORAL BIOAVAILABILITY OF DASATINIB.
    Furmanski, B.
    Fujita, K.
    Adachi, M.
    Li, L.
    Hu, S.
    Gibson, A.
    Leggas, M.
    Schuetz, J.
    Baker, S. D.
    Sparreboom, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S65 - S65
  • [45] Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity
    Wittgen, Hanneke G. M.
    van den Heuvel, Jeroen J. M. W.
    Krieger, Elmar
    Schaftenaar, Gijs
    Russel, Frans G. M.
    Koenderink, Jan B.
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (03) : 366 - 373
  • [46] The multidrug transporter MRP4/ABCC4 is a powerful marker of poor prognosis in neuroblastoma and a target for therapeutic suppression
    Norris, M. D.
    Smith, J.
    Flemming, C.
    Lyn, L.
    Allen, J.
    Cohn, S. L.
    London, W. B.
    Buxton, A.
    Marshhall, G. M.
    Haber, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 121 - 121
  • [47] Regulation of the basal promoter activity of the human MRP4 (ABCC4) transporter
    Kragl, A.
    Ziems, K.
    Glaubitz, J.
    Grammbauer, S.
    Broederdorf, S.
    Cole, S. P. C.
    Tzvetkov, M. V.
    Jedlitschky, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S37 - S37
  • [48] Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney
    Ci, Lei
    Kusuhara, Hiroyuki
    Adachi, Masashi
    Schuetz, John D.
    Takeuchi, Kenji
    Sugiyama, Yuichi
    MOLECULAR PHARMACOLOGY, 2007, 71 (06) : 1591 - 1597
  • [49] A Role For a Multi-Drug Resistance Protein (MRP4/ABCC4) In Pediatric Acute Myeloid Leukemia (AML)
    Lian, Shang Li
    Wang, Yao
    Zhou, Sheng
    Sukthankar, Mugdha
    Neale, Geoffrey A.
    Downing, James R.
    Schuetz, John D.
    BLOOD, 2013, 122 (21)
  • [50] MRP4 (ABCC4) PROTECTS CELLS FROM ARSENIC THROUGH THE EXPORT OF DIMETHYLARSINIC ACID (DMAV) AND THE DIGLUTATHIONE CONJUGATE OF MONOMETHYLARSONOUS ACID (MMAIII)
    Carew, Michael W.
    Banerjee, Mayukh
    Lu, Xiufen
    Naranmandura, Hua
    Le, X. Chris
    Leslie, Elaine M.
    DRUG METABOLISM REVIEWS, 2014, 45 : 244 - 245
12345